Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, 2-Way Crossover Study to Assess the PK of Intranasal Ketorolac Tromethamine and to Assess the Effects of a Single Dose of Oxymetazoline Hydrochloride on the PK of Intranasal Ketorolac Tromethamine in Healthy Male Subjects

NCT01363089 is registered in ClinicalTrials.gov with Egalet Ltd as lead sponsor.

NCT NCT01363089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01363089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, 2-Way Crossover Study to Assess the PK of Intranasal Ketorolac Tromethamine and to Assess the Effects of a Single Dose of Oxymetazoline Hydrochloride on the PK of Intranasal Ketorolac Tromethamine in Healthy Male Subjects
Lead sponsor
Egalet Ltd
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
February 29, 2008
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assess pharmacokinetics of ketorolac tromethamine intranasal and assess effects of a oxymetazoline hydrochloride on the pk of ketorolac tromethamine